The Carcinoembryonic Antigen (CEA) market has become a focal point within oncology diagnostics, reflecting significant advancements in biomarker testing and cancer management protocols. With rising incidences of colorectal and other cancers, the industry dynamics are shaped by evolving market drivers and regulatory landscapes impacting clinical adoption worldwide. Market Size and Overview The...